Class I phosphoinositide3-‐kinases in immunity…
119
71. Alcazar, I.; Cortes, I.; Zaballos, A.;Hernandez, C.; Fruman, D. A.; Barber, D. F.;&Carrera, A. C.
p85
β
phosphoinositide 3-‐kinase regulates CD28 coreceptor function.
Blood
113
, 3198-‐
3208(2009).
72. Oak, J. S.; Deane, J. A.; Kharas, M. G.; Luo, J.; Lane, T. E.; Cantley, L. C.; & Fruman, D. A.
Sjögren's syndrome-‐like disease inmicewith T cells lacking class 1Aphosphoinositide-‐3-‐
kinase.
ProcNatl AcadSci USA
103
, 16882-‐16887(2006).
73. Deane, J. A.; Kharas, M. G.; Oak, J. S.; Stiles, L. N.; Luo, J.; Moore, T. I.; Ji, H.; & al. T-‐cell
function is partially maintained in the absence of class IA phosphoinositide 3-‐kinase
signaling.
Blood
109
, 2894-‐2902(2007).
74. Rolf, J.; Bell, S. E.; Kovesdi, D.; Janas, M. L.; Soond, D. R.; Webb, L. M. C.; Santinelli, S.; & al.
Phosphoinositide 3-‐kinase activity in T cells regulates the magnitude of the germinal
center reaction.
J Immunol
185
, 4042-‐4052(2010).
75. Rodríguez-‐Borlado, L.; Barber, D. F.; Hernández, C.; Rodríguez-‐Marcos, M. A.; Sánchez, A.;
Hirsch, E.; Wymann, M.; & al. Phosphatidylinositol 3-‐kinase regulates the CD4/CD8 T cell
differentiationratio.
J Immunol
170
, 4475-‐4482(2003).
76. Garçon, F.; Patton, D. T.; Emery, J. L.; Hirsch, E.; Rottapel, R.; Sasaki, T.; & Okkenhaug, K.
CD28 provides T-‐cell costimulation and enhances PI3K activity at the immune synapse
independently of its capacity to interact with the p85/p110 heterodimer.
Blood
111
,
1464-‐1471(2008).
77. Thomas,M. S.;Mitchell, J. S.; DeNucci, C. C.;Martin, A. L.;&Shimizu, Y. Thep110
γ
isoformof
phosphatidylinositol 3-‐kinase regulates migration of effector CD4 T lymphocytes into
peripheral inflammatorysites.
J LeukocBiol
84
, 814-‐823(2008).
78. Martin, A. L.; Schwartz, M. D.; Jameson, S. C.; & Shimizu, Y. Selective regulation of CD8
effector T cellmigrationby the p110
γ
isoformof phosphatidylinositol 3-‐kinase.
J Immunol
180
, 2081-‐2088(2008).
79. Webb, L. M. C.; Vigorito, E.; Wymann, M. P.; Hirsch, E.; & Turner, M. Cutting edge: T cell
development requires the combined activities of the p110
γ
and p110
δ
catalytic isoforms
of phosphatidylinositol 3-‐kinase.
J Immunol
175
, 2783-‐2787(2005).
80. Bilancio, A.; Okkenhaug, K.; Camps, M.; Emery, J. L.; Ruckle, T.; Rommel, C.; &
Vanhaesebroeck, B. Key role of the p110
δ
isoform of PI3K in B-‐cell antigen and IL-‐4
receptor signaling: comparative analysis of genetic and pharmacologic interference with
p110
δ
function inBcells.
Blood
107
, 642-‐650(2006).
81. So, L.; Yea, S. S.; Oak, J. S.; Lu, M.; Manmadhan, A.; Ke, Q. H.; Janes, M. R.; & al. Selective
inhibitionof phosphoinositide3-‐kinasep110
α
preserves lymphocyte function.
J Biol Chem
288
, 5718-‐5731(2013).
82. Aragoneses-‐Fenoll, L.; Montes-‐Casado, M.; Herranz, J.; Acosta, Y. Y.; Martínez, S.; Blanco-‐
Aparicio, C.; Pastor, J.; &al. ETP-‐46321, adual p110
α
/
δ
class IAphosphoinositide3-‐kinase
inhibitor modulates CD28 and ICOS costimulation of CD4
+
T lymphocyte responses, cell
survival, and immune responses
invivo (Submitted)
(2013).
83. Shi, J.; Cinek, T.; Truitt, K. E.; & Imboden, J. B.Wortmannin, a phosphatidylinositol 3-‐kinase
inhibitor, blocks antigen-‐mediated, but not CD3monoclonal antibody-‐induced, activation
ofmurineCD4
+
Tcells.
J Immunol
158
, 4688-‐4695(1997).
84. Bain, J.; Plater, L.; Elliott, M.; Shpiro, N.; Hastie, C. J.; McLauchlan, H.; Klevernic, I.; &al. The
selectivityof proteinkinase inhibitors: a furtherupdate.
BiochemJ
408
, 297-‐315(2007).
85. Okkenhaug, K.; Patton, D. T.; Bilancio, A.; Garcon, F.; Rowan, W. C.; & Vanhaesebroeck, B.
The p110
δ
isoform of phosphoinositide 3-‐kinase controls clonal expansion and
differentiationof Thcells.
J Immunol
177
, 5122-‐5128(2006).
86. Haylock-‐Jacobs, S.; Comerford, I.; Bunting, M.; Kara, E.; Townley, S.; Klingler-‐Hoffmann, M.;
Vanhaesebroeck, B.; & al. PI3K
δ
drives the pathogenesis of experimental autoimmune
encephalomyelitis by inhibiting effector T cell apoptosis and promoting Th17
differentiation.
J Autoimmun
36
, 278-‐287(2011).
87. Soond, D. R.; Bjorgo, E.;Moltu, K.; Dale, V. Q.; Patton, D. T.; Torgersen, K. M.; Galleway, F.; &
al. PI3K p110
δ
regulates T-‐cell cytokine production during primary and secondary
immune responses inmiceandhumans.
Blood
115
, 2203-‐2213(2010).
88. Rolf, J.; Fairfax, K.; & Turner, M. Signaling pathways in T follicular helper cells.
J Immunol
184
, 6563-‐6568(2010).
